Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.0158
Handel nachbörslich:
.02
0.02
+
Nls Pharmaceutics Ag Aktie (NLSPW) Neueste Nachrichten
NLS Pharmaceutics Unveils Promising Narcolepsy Treatment - TipRanks
NLS Pharmaceutics highlights preclinical program for AEX-41, AEX-2 - TipRanks
NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders - AccessWire
NLS Pharmaceutics Advances Novel Dual Orexin Drug Platform in Key Preclinical Study | NLSPW Stock News - StockTitan
NLS Pharmaceutics AG Announces Share Capital Expansion - TipRanks
NLSP stock touches 52-week low at $3.15 amid market challenges - Investing.com
500: Something went wrong - Investing.com India
Kadimastem Ltd. Faces Financial Uncertainty - TipRanks
NLS Pharmaceutics announces merger with Kadimastem By Investing.com - Investing.com UK
NLS Pharmaceutics Announces Strategic Capital Restructuring - TipRanks
NLS and Kadimastem stocks soar following merger agreement - Yahoo Finance
NLS Pharmaceutics and Kadimastem to merge in biotech deal - Investing.com India
NLS Pharmaceutics and Kadimastem to merge in biotech deal By Investing.com - Investing.com UK
NLS Pharmaceutics stock jumps 50% on merger agreement with cell therapy firm Kadimastem - Seeking Alpha
NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement - AccessWire
NLSP stock touches 52-week low at $4 amid sharp annual decline - Investing.com Nigeria
NLSP stock touches 52-week low at $4 amid sharp annual decline By Investing.com - Investing.com South Africa
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements - AccessWire
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - MSN
NLS Pharmaceutics Secures Key Patent in Japan for Mazindol ER in the Treatment of Heroin Dependence - AccessWire
NLS Pharmaceutics Sees Reduced Losses Amid Financial Challenges - Yahoo Finance
NLS Pharmaceutics announces expected compliance with Nasdaq listing rules - TipRanks
NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules - AccessWire
NLS Pharmaceutics Launches New Share Purchase Warrant - TipRanks
NLS Pharmaceutics Regains Nasdaq Compliance - TipRanks
NLS Pharmaceutics AG announced that it expects to receive $3.201614 million in funding - Marketscreener.com
NLS Pharmaceutics Shareholders Approve Agenda - TipRanks
NLS Pharmaceutics Signs Option Agreement to Acquire Rights to Aexon Labs' Assets; Shares Rise - Marketscreener.com
NLS Pharmaceutics Receives Nasdaq Compliance Extension - TipRanks
NLSP stock touches 52-week high of $4.61 amid market fluctuations - Investing.com
NLS Pharmaceutics announces 1-for-40 reverse stock split - Investing.com
NLS Pharmaceutics Outlines Capital and Share Strategy - TipRanks
NLS Pharmaceutics announces 1-for-40 reverse share split - TipRanks
NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split - AccessWire
BREAKING: NPA to ballot pharmacists on working to rule - The Pharmacist
Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications - Yahoo Finance
Newell Brands Inc. (NASDAQ:NWL) Shares Bought by Primecap Management Co. CA - MarketBeat
National Beverage: Growth Fizzing Out With Questionable Earnings Quality - Seeking Alpha
London NHS trust paid out more than £1.3m in mental health claims in 5years - Time 107.5
North East London NHS trust pays out £1.3m in mental health negligence cases - Waltham Forest Echo
Keeping an Eye on Newell Brands Inc (NWL) After Insider Trading Activity - Knox Daily
GSK Velu’s Neuberg Diagnostics in talks with 360One, M&G Investments for $100 mn pre-IPO fundraise - Moneycontrol
Newell Brands Inc. (NASDAQ:NWL) Shares Bought by Arizona State Retirement System - Defense World
RSV medication among new Pharmac funding options - RNZ
NLS Pharmaceutics Plans Capital Increase and Debt Restructuring - TipRanks
Investor’s Toolkit: Key Ratios for Assessing NLS Pharmaceutics Ltd (NLSP)’s Performance - The Dwinnex
How To Buy NLS Pharmaceutics AG Stock Online in August 2024 - Traders Union
NLS Pharmaceutics (NASDAQ:NLSP) Trading 4.3% Higher - Defense World
NLS Pharmaceutics Gains PwC’s Endorsement - TipRanks
Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump - MSN
NLS Pharmaceutics to merge with Kadimastem in stock deal By Investing.com - Investing.com Nigeria
NLS Pharmaceutics Plans Merger with Kadimastem - TipRanks
NLS Pharmaceutics to merge with Kadimastem in stock deal - Investing.com India
0.93%
3.55%
Kapitalisierung:
|
Volumen (24h):